Grellier
Andre Grellier, Saint Georges De Mons FR
Patent application number | Description | Published |
---|---|---|
20080302501 | Steel for Hot Tooling, and Part Produced From Said Steel, Method for the Production Thereof, and Uses of the Same - The invention relates to steel for hot tooling, the composition of said steel being made up of the following weight percentages: 0.30%=C=0.39%, 4.00%=Cr=6.00%, traces=Si=0.50%, traces=Mn=0.80%, traces=W=1.45%, traces=Co=2.75%, 0.80%=Ni=2.80%, 1.50%=Mo=2.60% with 1.50%=Mo+0.65W=3.20%, 0.55%=V=0.80%, with 0.65=K=0.65, where K=K2−K1 and K2=0.75×(Ni 0.60), K1=1.43×(V0.40)+0.63×[(Mo+0.65W) 1.20], traces=Al=0.080%, traces=S=0.0040%, traces=P=0.0200%, traces=Ti=0.05%, traces=Zr=0.05%, traces=Nb=0.08%, traces=N=0.040%, 10P+As+5Sb+4Sn=0.21%, traces=O=30 ppm, the remainder being iron and inevitable impurities. The invention also relates to a part produced from said steel, to the method for the production thereof, and to the use of the same. | 12-11-2008 |
Andre Francis Grellier, Saint-Georges-De-Mons FR
Patent application number | Description | Published |
---|---|---|
20100276038 | MARTENSITIC STAINLESS STEEL, METHOD FOR MAKING PARTS FROM SAID STEEL AND PARTS THUS MADE - Martensitic stainless steel, characterised in that it comprises, in percentages by weight: | 11-04-2010 |
Benoît Grellier, Strasbourg FR
Patent application number | Description | Published |
---|---|---|
20110081353 | ANTIBODY AGAINST THE CSF-1 R - The present invention provides antibodies specific for the CSF-1R, compositions comprising said antibodies and methods of treatment using such compositions. | 04-07-2011 |
20110178278 | Antibody Against the CSF-1R - The present invention provides antibodies specific for the CSF-1R, compositions comprising said antibodies and methods of treatment using such compositions. | 07-21-2011 |
Benoît Grellier, Strasbourg FR
Patent application number | Description | Published |
---|---|---|
20110081353 | ANTIBODY AGAINST THE CSF-1 R - The present invention provides antibodies specific for the CSF-1R, compositions comprising said antibodies and methods of treatment using such compositions. | 04-07-2011 |
20120115249 | Biomarker for Selecting Patients and Related Methods - The present invention concerns biomarkers and use thereof for determining whether a subject is or is not susceptible to developing a prophylactic or therapeutic immune response after such treatment. | 05-10-2012 |
20130289250 | ANTIBODY AGAINST THE CFR-1R - The present invention provides antibodies specific for the CSF-1R, compositions comprising said antibodies and methods of treatment using such compositions. | 10-31-2013 |
20140057972 | ANTIBODY AGAINST THE CSF-1R - The present invention provides antibodies specific for the CSF-1R, compositions comprising said antibodies and methods of treatment using such compositions. | 02-27-2014 |
Edouard Grellier, Massy FR
Patent application number | Description | Published |
---|---|---|
20140334815 | SYSTEM AND METHOD FOR SELECTING AN OPTICAL PATH IN AN OPTICAL NETWORK - The invention proposes a system and method for selecting an optimal optical path through which to transmit an optical signal, the optimal optical path is one of a plurality of optical paths in a transparent optical network. Each of the plurality of optical paths includes a plurality of optical elements. For each of the plurality of optical paths, a first optical signal to noise ratio is determined for each optical element in the respective optical path. Then, for each of the plurality of optical paths, nonlinear distortions caused by each optical element in the respective optical path are modelled as Gaussian noise and a second optical signal to noise ratio associated with the modelled Gaussian noise is determined. Finally, the optimal optical path is selected using the sums of the first and second optical signal to noise ratios, respectively. | 11-13-2014 |
Elodie Grellier, Cachan FR
Patent application number | Description | Published |
---|---|---|
20140341857 | COMBINATION OF ONCOLYTIC ADENOVIRUSES WITH HISTONE DEACETYLASE INHIBITORS - The invention relates to the use of oncolytic adenoviruses with histone deacetylase inhibitors in combination therapy for cancer treatment. | 11-20-2014 |
Marc Grellier, Sorigny FR
Patent application number | Description | Published |
---|---|---|
20150276023 | Power Transmission Belt With Thermoplastic Film Containing A Silicone Elastomer - A power transmission belt having elastomer teeth based on an ethylene alpha-olefin elastomer, provided with an external film, is provided in which the external film is based on a thermoplastic olefin, the thermoplastic of the film being associated with a silicone elastomer that represents at least 20% by weight of the total weight of the film and with a compatibilizing element that ensures, within the film, compatibility between the thermoplastic and the silicone elastomer. | 10-01-2015 |
Michel Grellier, Fresnes FR
Patent application number | Description | Published |
---|---|---|
20160129758 | GRATING FOR HOMOGENIZING A FLOW OF AIR AND CORRESPONDING HEATER UNIT - The invention concerns a grid ( | 05-12-2016 |
Stephane Grellier, Meudon FR
Patent application number | Description | Published |
---|---|---|
20120030121 | SECURE ACTIVATION BEFORE CONTACTLESS BANKING SMART CARD TRANSACTION - The invention relates to a portable token equipped with non-volatile memory, the token comprising authentication means to authenticate a holder of the token, authorization means to define the rights of the holder, and payment means to trigger a payment transaction. The authorization means are set to store the rights in non-volatile memory after the authentication means are invoked, and the payment means have the capacity to retrieve the rights from non-volatile memory, and to subject the execution of the payment transaction to the verification of the rights. The invention also relates to a related portable device, to a system comprising a portable token and a portable token, and to a method for carrying out a payment transaction with a portable token. | 02-02-2012 |